| Cell line name |
LC-99A |
|---|
| Synonyms |
LC99A |
|---|
| Accession |
CVCL_A1KV |
|---|
| Resource Identification Initiative |
To cite this cell line use: LC-99A (RRID:CVCL_A1KV) |
|---|
| Comments |
Population: Japanese. |
|---|
| HLA typing |
Source: PubMed=9023415
| Class I | | HLA-A | A*24:02 | | HLA-B | B*52:01,54:01 | | HLA-C | C*01:02,12:02 |
|
|---|
| Disease |
Lung large cell carcinoma (NCIt: C4450) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Sex unspecified |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=7671230
Nakao M., Yamana H., Imai Y., Toh Y., Toh U., Kimura A., Yanoma S., Kakegawa T., Itoh K.
HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma.
Cancer Res. 55:4248-4252(1995) PubMed=9023415; DOI=10.1006/cimm.1996.1062
Seki N., Hoshino T., Kikuchi M., Hayashi A., Itoh K.
HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
Cell. Immunol. 175:101-110(1997) PubMed=9538136; DOI=10.3892/ijo.12.5.1103
Takaki T., Hiraki A., Uenaka A., Gomi S., Itoh K., Udono H., Shibuya A., Tsuji T., Sekiguchi S., Nakayama E.
Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 peptide recognized by cytotoxic T lymphocytes.
Int. J. Oncol. 12:1103-1109(1998) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q102114455
|
|---|
| Entry history |
|---|
| Entry creation | 29-Oct-2020 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 3 |
|---|
